| Stage | OTIS | % of rev | GE | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $3.9B | 100.00% | $14.1B | 100.00% | GE ×3.61 |
| Gross profit | $1.2B | 29.51% | $5.0B | 35.57% | GE +6.1pp |
| Operating income | $620M | 15.84% | $2.6B | 18.45% | GE +2.6pp |
| Pre-tax income | $552M | 14.10% | $2.8B | 19.87% | GE +5.8pp |
| Net income | $426M | 10.88% | $2.3B | 16.26% | GE +5.4pp |
| Stage | OTIS | GE | Gap · A − B |
|---|---|---|---|
| Revenue | $3.9B100.00% | $14.1B100.00% | GE ×3.61 |
| Gross profit | 29.51%$1.2B | 35.57%$5.0B | GE +6.1pp |
| Operating income | 15.84%$620M | 18.45%$2.6B | GE +2.6pp |
| Pre-tax income | 14.10%$552M | 19.87%$2.8B | GE +5.8pp |
| Net income |
| 10.88%$426M |
| 16.26%$2.3B |
| GE +5.4pp |
None
No disclosed counterparties: OTIS.